Cellnex

18/11/25 -"Following the Q3 release, we have made minor adjustments to our figures. While EBITDA remains mostly unchanged, there is a slight increase in D&A, resulting in a decrease in EPS. Although this ..."

PDF page sample
Pages
57
Language
English
Published on
18/11/25
Download
You may also be interested by these reports :
18/11/25
Following the Q3 release, we have made minor adjustments to our figures. While EBITDA remains mostly unchanged, there is a slight increase in D&A, ...
13/11/25
Revenue and EBITDA growth in Germany and the rest of Europe slightly slowed in Q3, aligning with the lower end of the consensus range. TMUS and DT ...
11/11/25
The Q3 performance is satisfactory. The anticipated sale of Sedo is expected to be well-received by the market, as it is the Ionos business activity ...
11/11/25
Vodafone’s H1 results are reassuring. Germany is on a clear improvement path, and emerging markets are experiencing robust growth. In the UK, ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO